NextCell reports numerically favorable results in younger children
12-month data show preserved insulin production at ages 7–11, but the study missed its primary endpoint. The adult strategy remains unchanged.
See the latest news and media coverage for NextCell. We track all announcements, press releases, and industry mentions in real time, all in one place.
Stem cell therapy and biobanking company
nextcellpharma.comLast updated
In short: NextCell reported mixed ProTrans-Young results, launched FUJIFILM product and expanded in Asia
12-month data show preserved insulin production at ages 7–11, but the study missed its primary endpoint. The adult strategy remains unchanged.
The company reports quarterly results and expands its presence in Asia with new offices in Hong Kong as well as an EU-Japan assignment.
Net sales amounted to three million SEK while the operating result was minus eleven. The company is launching a new product with FUJIFILM and expanding to Hong Kong.
The company carried out a directed issuance of SEK 15 million and presented long-term data for NXTCL-T1D, as well as launched new products in Japan and Hong Kong.
NextCell Pharma AB has released its financial results for the second quarter and the first half year ended June 30, 2026. For the second quarter...
On this page, you'll find detailed information about the financial performance of NextCell Pharma AB, including the latest NextCell Pharma AB earnings report and upcoming...
Collaboration results in platform to help researchers overcome challenges in MSC research...
Collaboration results in platform to help researchers overcome challenges in MSC researchNextCell-Cord RUO cells designed for delivery as cryopreserved and sold as an individual product...
Track NextCell and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to NextCell and other trending companies.